glutathione p PatchAid Plus Patch Using patented technology Liposomal Glutathione - Lypo-Spheric® Glutathione

The global IV therapy market is projected to grow at a compound annual rate exceeding 7% through 2030, driven by aging populations, chronic disease prevalence, and increasing consumer sophistication about micronutrient status

Exclusion criteria for all groups included current or previous psychiatric comorbidities as diagnosed by DSM-5, using a structured interview (The Structured Clinical Interview for DSM-5, SCID-5) [28] if deemed relevant by the investigator, any general medical conditions known to influence energy processing and/or linked to fatigue, current treatment with any medication/supplementation likely to interfere with energy metabolism if deemed relevant by the investigator, contra-indications to magnetic resonance (MR) imaging, pregnancy or breast feeding

Sure we can ship order to your clients directly

Discover how IV therapy strengthens outcomes in regenerative orthopedics

Gandhi RT, Lynch JB, Del Rio C